The American Diabetes Association has announced the departure of its chief scientific and medical officer, Rita Kalyani, effective immediately. This follows a state of turmoil following the June 5 incident where five members were escorted out by armed security officers for an April editorial in the ADA’s journal, expressing concern about cuts to federal research funding. The organization is working to address the issues that led to Kalyani's departure and maintain its mission and reputation.
Key points
The American Diabetes Association has announced the departure of its chief scientific and…: The American Diabetes Association has announced the departure of its chief scientific and medical officer, Rita Kalyani, effective immediately.
The organization has been in a state of turmoil since June 5, following the incident wher…: The organization has been in a state of turmoil since June 5, following the incident where five members were escorted out by armed security officers for an April editorial in the ADA’s journal, expressing concern about cuts to federal research funding.
The organization is working to address the issues that led to Kalyani's departure and mai…: The organization is working to address the issues that led to Kalyani's departure and maintain its mission and reputation.
Sources checked by our analysis pipeline: 1
Just over six weeks after the American Diabetes Association said its review of an incident at its New Orleans meeting in June would need more time, one of its top leaders is out.
Rita Kalyani, chief scientific and medical officer, “is no longer in her role, effective immediately,” Tuesday’s notice from the ADA said. “We thank Dr. Kalyani for her dedication to the ADA’s mission over the years,” CEO Charles Henderson said.
The organization has been in some turmoil since June 5, when five members were escorted out by armed security officers for handing out an April editorial, published in the ADA’s journal Diabetes Care, that voiced alarm over cuts to federal research funding.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Pope Leo XIV, battling lung cancer for 17 months, has been cleared of any further treatment after follow-up tests confirmed the disease was localized. The 71-year-old pope had the lower lobe of his right lung removed last week as part of his 17-month pontificate.
Pope Leo XIV has been discharged from Gemelli Hospital after undergoing surgery to remove a lung adenocarcinoma, confirming initial diagnosis. The 71-year-old Pope has resumed speaking to well-wishers and has held his first general audience since leaving the hospital. He has also engaged in phone calls with Russian President Vladimir Putin and Ukrainian President Volodymyr Zelensky, urging a ceasefire for aid delivery and calling for dialogue and peace. The pontiff plans to visit Latin America in early November.
The Centers for Disease Control and Prevention (CDC) has been criticized for ignoring a request from several states to validate a new measles test developed by the agency. The new test, which is designed to detect the virus more accurately, has not been approved by the CDC and cannot be used in the United States. The states have been calling for the test to be validated, but the CDC has refused to do so, citing concerns about the test's accuracy.